NEW MEDICAL TECHNOLOGIES FOR THE MANAGEMENT OF PATIENTS WITH UROGENITAL MYCOPLASMA INFECTION
The Federal Service for Surveillance in Health Care and Social Development has developed and approved the new medical technology "Indications and treatment policy in patients with urogenital mycoplasma infection in relation to the genetic variability of genital mycoplasmas" (FS No. 2010/007 dated January 26, 2010), which defines indications for examination and therapy depending on the results of comprehensive assessment of clinical and laboratory examinations in patients with Mycoplasma-associated urogenital infection.